Researchers from the University of Alabama at Birmingham have identified a promising new combination therapy for metastatic ...

Transaction Will Maximize the Access and Uptake of COSELA® (trilaciclib), the First and Only Proactive Multilineage ...

This, in turn, prompts the downregulation of cyclin D2 and the upregulation of the p27kip1 protein, eventually leading to cell cycle arrest at the G1 phase. In terms of angiogenesis, HGF stimulates ...

Happy birthday to the world's first ever mirrorless camera, which just turned 16 years old! But is it still usable in 2024?

Trilaciclib is under clinical development by G1 Therapeutics and currently in Phase III for Triple-Negative Breast Cancer (TNBC).

Patients with cancer cachexia and an elevated level of growth differentiation factor 15 (GDF-15) achieved significant ...

Promising Triple Negative Breast Cancer Pipeline Therapies in the various stages of development include Nanosomal Docetaxel ...

Patients with advanced SSC of the anal canal have a marked survival benefit when immunotherapy is added to standard-of-care ...

SlashGear's Best Of IFA 2024 includes a variety of gadgets and appliances that have a good chance of making a meaningful ...

Shares in iTeos Therapeutics dropped over 20% despite positive interim data from the GALAXIES Lung-201 Phase II study with ...